Trump Trade War Threatens U.S. Chemical Investment Renaissance
(Bloomberg) -- A brewing trade war with China threatens to derail the fastest-growing sector of the U.S. manufacturing economy as chemical companies rethink spending almost $100 billion on new factories.
Tariffs on U.S. chemical exports to China, coupled with new duties on steel imports used to build plants, would undercut the economic advantage that's fueled the industry's unprecedented expansion. Contrary to President Donald Trump's pledge to bring manufacturing back home, companies that expand production or build facilities outside the U.S. would reduce capital expenses while avoiding Chinese tariffs.
“Market shifts caused by tariff increases may convince investors to do business elsewhere,” said Cal Dooley, president of the American Chemistry Council trade group. Current plans for new chemical factories, expansions and restarts of facilities in the U.S. were based on the economics of existing tariffs, he said in a statement Wednesday.
China's proposal to levy 25 percent tariffs on about $50 billion of U.S. imports effectively would remove a large market for dozens of plastics and chemicals targeted by the measure. China imported $3.2 billion of U.S. plastic resins last year, making the country one of the industry's most important trading partners, Dooley said. Forty percent of the products on China's tariffs list are chemicals such as polyethylene, PVC, polycarbonates and acrylates.
Quickly Escalating
The Wednesday announcement was retaliation against Trump's proposals for $50 billion in similar tariffs for China imports. That followed a 25 percent duty the U.S. imposed on steel imports -- a move that DowDuPont Inc. already warned would add $300 million to a major chemical project on the U.S. Gulf Coast.
The new tariffs strengthen the case for DowDupont to locate its next big plant in a country like Argentina or Canada, said Jim Fitterling, chief operating officer of the company's Dow chemicals unit. Dow just completed a $6 billion Texas expansion, and higher steel costs don't help the case for another U.S. project, he said.
“You eventually get yourself to the point where you are saying, ‘Should I really be building that here or somewhere else?'” Fitterling said in a March 6 interview.
Shale Advantage
Chemical production has emerged as the biggest driver of U.S. manufacturing growth in recent years as the shale drilling boom lowered the costs of key raw materials such as ethane, according to the American Chemistry Council, an industry advocate. Cheap natural gas liquids like ethane give the U.S. a competitive edge over producers elsewhere that use oil-derived naphtha as a raw material.
The advantage prompted chemical makers to announce investments of $188 billion for new U.S. production, with more than half of the projects not yet begun, according to a chemistry council tally.
Companies with factories inside China or elsewhere outside the U.S. should be able to avoid China's new levy, said Christopher Perrella, a chemicals analyst with Bloomberg Intelligence. The low-cost position of U.S. plastics means the exports will find a market somewhere, even if supply chains need to shift, he said.
Even before the latest round of tariffs, Chevron Phillips Chemical Co. was growing wary of rising plant construction costs that threatened plans for another U.S. project. Construction costs are up 40 percent over five years, Doug May, a DowDuPont business president, said March 21.
To contact the reporter on this story: Jack Kaskey in Houston at jkaskey@bloomberg.net.
To contact the editors responsible for this story: Brendan Case at bcase4@bloomberg.net, Susan Warren
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.